NCT07621237 clinical trial report covering Cyclobenzaprine hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07620561 clinical trial report covering Lebrikizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07620938 clinical trial report covering TJ-0113, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07620366 clinical trial report covering QL2401, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07621562 clinical trial report covering Sintilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20262036 clinical trial report covering LY-4395089, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07621484 clinical trial report covering Serplulimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07619911 clinical trial report covering Retlirafusp alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07619950 clinical trial report covering Everolimus, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07622017 clinical trial report covering Hydrogen Peroxide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07619898 clinical trial report covering Methoxsalen, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07620548 clinical trial report covering Cemiplimab-RWLC, Phase 2, endpoints, sponsor, geography, readout timing and development white space.